Do you have an enlarged prostate and are taking medication for it?
If you are taking a an enlarged prostate medication such as Flomax, Tamsulosin, Finasteride or another enlarged prostate medication, you may be eligible to participate in this program
Managing your benign prostatic hyperplasia (BPH) alone may not be enough.
If you are on BPH therapy and visiting the bathroom frequently, you may have an overactive bladder (OAB).
The immediate need to ‘go’ interrupts your day and night – and it may not be caused by your BPH.
- Do you have to use the bathroom at least 8 times a day?
- Do you still wake up 2 or more times each night to use the bathroom
- Do you experience a need to use the bathroom immediately (urinary urgency)?
If these symptoms disrupt your day and night, you may also have a condition called OAB.
Can I take part?
To determine whether you are eligible to take part in the cutting edge program, you first need to fill out the form or call us. Then, you will be invited to visit our center to undergo medical tests and assessments. If eligible, you will be asked to return to undergo further tests. Participants will have the opportunity to try a potential new overactive bladder medicine at no cost and will be reimbursed for their time, travel and/or meals.
About the Progrram
Our program is testing the safety and effectiveness of an investigational overactive bladder medication for men who have an enlarged prostate and are taking medication for their enlarged prostate
OAB is highly prevalent and affects approximately 16% of the population in the United States and Europe. Prevalence increases with age, affecting approximately one third of people 75 years and older [Stewart, 2003; Milsom, 2001]. Despite similar prevalence between the sexes and growing clinical trial evidence that men benefit from pharmacotherapy, men are less likely to use treatment for OAB [Goldman, 2016].
What happens at the end of the study?
If you find this program works for you, you may be able to get an extension period along with additional reimbursement. If you do not join the extension study, you will receive a telephone call from the study team 3 weeks after your last dose of the study drug to check on your overall health and well-being.